English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Lavie Bio announces commercial expansion of its bio-inoculant product, Yalos™, to winter wheatqrcode

−− Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season

Jul. 3, 2024

Favorites Print
Forward
Jul. 3, 2024

Lavie Bio
Israel  Israel
Follow

Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN),  announced the commercial expansion of its bio-inoculant product, Yalos™, to winter wheat, following successful trials. This expansion effectively doubles the potential market for Yalos™ compared to markets in which Lavie Bio already operates. Winter wheat growers across the US will have access to Yalos™ for the upcoming 2024-2025 season.


Winter wheat is one of the crucial crops in North America and globally, significantly contributing to the agricultural economy and food supply. The US is expected to produce about 1.28 billion bushels in 2024[1], with a market value, according to Lavie Bio's estimation, between $5-$10 billion annually. Introducing Yalos™ to this market offers substantial potential to capture market share by enhancing crop productivity and sustainability. To date, Lavie Bio has focused on the spring wheat market, along with durum and barley, which together form a smaller market compared to winter wheat.


During the successful field trials, Yalos™ has demonstrated enhanced early vigor, biomass, root and shoot development, nutrient availability, and feed quality in winter wheat. Yalos™ aims to reduce crop abandonment rates and increase farm productivity through advanced biological technologies.


In addition, Lavie Bio is expecting to expand Yalos™ into other key crops, such as soybean and canola, with ongoing field trials in North America and an expected commercial launch in 2025. The US soybean market size is estimated by Lavie Bio at approximately $56.2 billion in 2024.


"We are thrilled to offer Yalos™ to winter wheat growers," said Amit Noam, CEO of Lavie Bio. "Yalos™ addresses key growth challenges and enhances plant health and yield. Our strategy consistently brings new innovative ag-biological products to the market, while expanding existing products to more crops and regions. This expansion is part of our plan for Yalos™ to become a leading solution for growers in all major field crops, reinforcing our commitment to advancing agricultural productivity and sustainability on a global scale."


[1] https://www.nass.usda.gov/Newsroom/2024/05-10-2024.php


BioEx2025-02_副本.jpg

6th Biopesticides, Biostimulants and Biofertilizers Summit (BioEx 2025)


BioEx 2025 is now in preparation, and you are welcome to consult and collaborate with us!

 Submit speech abstract  |  Become a sponsor  |  Become an exhibitor  |    Previous BioEx  


Contact: Christina Xie

Email: christina@agropages.com

Mobile (WeChat/WhatsApp): +86 18806513367

Source: Lavie Bio

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox